Category
Amoxicillin
CAS Number
205826-86-4
Molecular Formula
C₁₃H₁₇NO₄
Molecular Weight
251.3 g/mol
Synonym

(2R)-2-[(2,2-dimethylpropanoyl)amino]-2-(4- hydroxyphenyl)acetic acid;
(2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-(4-hydroxyphenyl)acetic acid (as per EP) ; ((R)-2-(4-Hydroxyphenyl)-2-pivalamidoacetic acid) (as per USP);Amoxicillin USP Related Compound H;

Keywords
High-Quality Pharmaceutical Reference Standards
Pharmaceutical Standards
Intermediates
Impurities
Impurities manufacturer and Suppliers in Hyderabad india
Impurities Manufacturer in India
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Amoxicillin EP Impurity H (CAS No.: 205826-86-4; Molecular Formula: C₁₃H₁₇NO₄; Molecular Weight: 382.4 g/mol) is a specialized pharmaceutical analytical compound used for evaluating Amoxicillin-related substances and supporting API quality assessment, chromatographic profiling, chemical identity verification, impurity surveillance, degradation assessment, and stability-indicating studies. It is applicable in analytical procedure optimization, pharmaceutical substance characterization, specification compliance testing, HPLC investigations, and research-driven impurity evaluation, making it valuable for pharmaceutical laboratories and analytical development teams. Manasa Life Sciences is a trusted Indian manufacturer and global supplier of Amoxicillin EP Impurity H, delivering pharmacopoeial-related reference materials, analytical research substances, and API characterization compounds with reliable traceability, defined specifications, consistent quality, and supporting documentation for drug development, quality assurance, formulation studies, analytical research, and regulatory laboratory work across India, Asia, Europe, Africa, GCC, UAE, Saudi Arabia, and other international markets.